Literature DB >> 9342312

On roads not taken in the evolution of protein catalysts: antibody steroid isomerases that use an enamine mechanism.

C H Lin1, T Z Hoffman, P Wirsching, C F Barbas, K D Janda, R A Lerner.   

Abstract

Reactive immunization has emerged as a new tool for the study of biological catalysis. A powerful application resulted in catalytic antibodies that use an enamine mechanism akin to that used by the class I aldolases. With regard to the evolution of enzyme mechanisms, we investigated the utility of an enamine pathway for the allylic rearrangement exemplified by Delta5-3-ketosteroid isomerase (KSI; EC 5.3.3.1). Our aldolase antibodies were found to catalyze the isomerization of both steroid model compounds and steroids. The kinetic and chemical studies showed that the antibodies afforded rate accelerations up to a factor of 10(4) by means of an enamine mechanism in which imine formation was the rate-determining step. In light of our observations and the enzyme studies by other workers, we suggest that an enamine pathway could have been an early, viable KSI mechanism. Although this pathway is amenable to optimization for increased catalytic power, it appears that certain factors precluded its evolution in known KSI enzymes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342312      PMCID: PMC23568          DOI: 10.1073/pnas.94.22.11773

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  The delta 5-3-ketosteroid isomerase reaction: catalytic mechanism, specificity and inhibition.

Authors:  F H Batzold; A M Benson; D F Covey; C H Robinson; P Talalay
Journal:  Adv Enzyme Regul       Date:  1976

2.  Nature of the intermediate in the 3-oxo-delta 5-steroid isomerase reaction.

Authors:  B F Zeng; P L Bounds; R F Steiner; R M Pollack
Journal:  Biochemistry       Date:  1992-02-11       Impact factor: 3.162

Review 3.  Fructose-bisphosphate aldolases: an evolutionary history.

Authors:  J J Marsh; H G Lebherz
Journal:  Trends Biochem Sci       Date:  1992-03       Impact factor: 13.807

4.  Combined effects of two mutations of catalytic residues on the ketosteroid isomerase reaction.

Authors:  A Kuliopulos; P Talalay; A S Mildvan
Journal:  Biochemistry       Date:  1990-11-06       Impact factor: 3.162

5.  Catalytic mechanism of an active-site mutant (D38N) of delta 5-3-ketosteroid isomerase. Direct spectroscopic evidence for dienol intermediates.

Authors:  L A Xue; A Kuliopulos; A S Mildvan; P Talalay
Journal:  Biochemistry       Date:  1991-05-21       Impact factor: 3.162

6.  Studies of the catalytic mechanism of an active-site mutant (Y14F) of delta 5-3-ketosteroid isomerase by kinetic deuterium isotope effects.

Authors:  L A Xue; P Talalay; A S Mildvan
Journal:  Biochemistry       Date:  1991-11-12       Impact factor: 3.162

Review 7.  A data-based reaction mechanism for type I fructose bisphosphate aldolase.

Authors:  J A Littlechild; H C Watson
Journal:  Trends Biochem Sci       Date:  1993-02       Impact factor: 13.807

8.  A catalytic antibody isomerizing a delta 5-3-cétostéroïde.

Authors:  B Khettal; S de Lauzon; B Desfosses; S Ushida; A Marquet
Journal:  C R Acad Sci III       Date:  1994-05

9.  Influence of the position of the double bond in steroid substrates on the efficiency of the proton-transfer reaction by Pseudomonas testosteroni 3-oxo-steroid delta 4-delta 5-isomerase.

Authors:  H Weintraub; E E Baulieu; A Alfsen
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

10.  Lysine-146 of rabbit muscle aldolase is essential for cleavage and condensation of the C3-C4 bond of fructose 1,6-bis(phosphate).

Authors:  A J Morris; D R Tolan
Journal:  Biochemistry       Date:  1994-10-11       Impact factor: 3.162

View more
  6 in total

1.  Catalytic and binding poly-reactivities shared by two unrelated proteins: The potential role of promiscuity in enzyme evolution.

Authors:  L C James; D S Tawfik
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  A cofactor approach to copper-dependent catalytic antibodies.

Authors:  Kenneth M Nicholas; Paul Wentworth; Curtis W Harwig; Anita D Wentworth; Asher Shafton; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

3.  Structural evidence for a programmed general base in the active site of a catalytic antibody.

Authors:  B Golinelli-Pimpaneau; O Goncalves; T Dintinger; D Blanchard; M Knossow; C Tellier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  Mechanism of an antibody-catalysed allylic isomerization.

Authors:  O Gonçalves; T Dintinger; J Lebreton; D Blanchard; C Tellier
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

5.  Asymmetric approach toward chiral cyclohex-2-enones from anisoles via an enantioselective isomerization by a new chiral diamine catalyst.

Authors:  Jung Hwa Lee; Li Deng
Journal:  J Am Chem Soc       Date:  2012-10-22       Impact factor: 15.419

6.  BIMP-Catalyzed 1,3-Prototropic Shift for the Highly Enantioselective Synthesis of Conjugated Cyclohexenones.

Authors:  Jonathan C Golec; Eve M Carter; John W Ward; William G Whittingham; Luis Simón; Robert S Paton; Darren J Dixon
Journal:  Angew Chem Int Ed Engl       Date:  2020-08-07       Impact factor: 16.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.